Efferon
PrivateLast Round
Series A
Jun 3, 2026
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Efferon is a therapeutic devices company that develops and manufactures advanced therapeutic devices for the treatment of sepsis and multiple organ failure syndrome through innovative extracorporeal blood purification technologies.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Efferon Comparables
Compare Efferon with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alteco Medical AB | 88% | |
| ExThera Medical | 83% | |
| Cytosorbents Corporation | 83% | |
Efferon Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 3, 2026 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 3, 2026
$3M raised in Seed round.
- May 19, 2026
Monthly visitors grew 234% MoM, reaching 4.6K.
Efferon Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Efferon's valuation, stock price, and market status.